ABANZA
Juan Abascal
Founder & CEO

ABANZA has developed a disruptive soft tissue fixation platform designed to meet the needs of new patient demographics. Its first FDA-cleared products, WasherCap™ and QuadLock™, deliver the lowest cyclic displacement on the market and allow surgeons to re-tension fixation at any point during surgery. Initially focused on the knee, ABANZA is expanding into foot and ankle, hand and wrist, hip, and shoulder applications, ushering in A New Era in Soft Tissue Fixation.